{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:49:20Z","timestamp":1767844160869,"version":"3.49.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005229","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000}}],"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006512","name":"Duke University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005229","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T17:55:52Z","timestamp":1481565352000},"page":"e0005229","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy"],"prefix":"10.1371","volume":"10","author":[{"given":"Bryan E.","family":"Hart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7169-6736","authenticated-orcid":true,"given":"Sunhee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clindermatol.2008.09.021","article-title":"Buruli ulcer","volume":"27","author":"F Portaels","year":"2009","journal-title":"Clinics in dermatology"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7883\/yoken.66.83","article-title":"Buruli ulcer and mycolactone-producing mycobacteria","volume":"66","author":"K Nakanaga","year":"2013","journal-title":"Japanese journal of infectious diseases"},{"issue":"17","key":"ref3","first-page":"145","article-title":"Buruli ulcer: progress report, 2004\u20132008","volume":"83","year":"2008","journal-title":"Releve epidemiologique hebdomadaire \/ Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record \/ Health Section of the Secretariat of the League of Nations"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1039\/c3np70068b","article-title":"History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease)","volume":"30","author":"AC Chany","year":"2013","journal-title":"Natural product reports"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4161\/hv.7.11.17751","article-title":"Buruli ulcer","volume":"7","author":"T Einarsdottir","year":"2011","journal-title":"Human vaccines"},{"issue":"2","key":"ref6","first-page":"144","article-title":"Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era","volume":"6","author":"BJ Webb","year":"2009","journal-title":"East African journal of public health"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"e3303","DOI":"10.1371\/journal.pntd.0003303","article-title":"Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin","volume":"8","author":"J de Zeeuw","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"ref8","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/inthealth\/ihv071","article-title":"Social stigma towards neglected tropical diseases: a systematic review","volume":"8","author":"K Hofstraat","year":"2016","journal-title":"Int Health"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"e2739","DOI":"10.1371\/journal.pntd.0002739","article-title":"Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial","volume":"8","author":"S Klis","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-009-0109-6","article-title":"Buruli ulcer disease: prospects for a vaccine","volume":"198","author":"K Huygen","year":"2009","journal-title":"Medical microbiology and immunology"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1371\/journal.pntd.0000985","article-title":"BCG-mediated protection against Mycobacterium ulcerans infection in the mouse","volume":"5","author":"PJ Converse","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"e2604","DOI":"10.1371\/journal.pntd.0002604","article-title":"Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice","volume":"8","author":"V Roupie","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","article-title":"Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer","volume":"69","author":"A Tanghe","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1371\/journal.pntd.0000199","article-title":"Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting","volume":"2","author":"A Tanghe","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"e0004046","DOI":"10.1371\/journal.pntd.0004046","article-title":"Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer","volume":"9","author":"BE Hart","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"19","key":"ref16","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.vaccine.2015.03.046","article-title":"Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice","volume":"33","author":"M Watanabe","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"e0004011","DOI":"10.1371\/journal.pntd.0004011","article-title":"Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease","volume":"9","author":"M Bolz","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e0004431","DOI":"10.1371\/journal.pntd.0004431","article-title":"Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer","volume":"10","author":"M Bolz","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"87","key":"ref19","doi-asserted-by":"crossref","first-page":"20130365","DOI":"10.1098\/rsif.2013.0365","article-title":"Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered","volume":"10","author":"C Dye","year":"2013","journal-title":"Journal of the Royal Society, Interface \/ the Royal Society"},{"issue":"1","key":"ref20","first-page":"53","article-title":"History of BCG Vaccine","volume":"8","author":"S Luca","year":"2013","journal-title":"Maedica"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.72.1.62-65.2004","article-title":"Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease","volume":"72","author":"F Portaels","year":"2004","journal-title":"Infection and immunity"},{"issue":"6","key":"ref22","first-page":"1389","article-title":"Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer)","volume":"9","author":"F Portaels","year":"2002","journal-title":"Clinical and diagnostic laboratory immunology"},{"issue":"5\u20136","key":"ref23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(76)90128-0","article-title":"The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda","volume":"70","author":"PG Smith","year":"1976","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"ref24","article-title":"Vaccination against tuberculosis with whole cell mycobacterial vaccines","author":"TJ Scriba","year":"2016","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fimmu.2014.00152","article-title":"Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting Memory","volume":"5","author":"AC da Costa","year":"2014","journal-title":"Front Immunol"},{"issue":"5\u20136","key":"ref26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.micinf.2005.04.002","article-title":"Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins","volume":"7","author":"MA Horwitz","year":"2005","journal-title":"Microbes and infection \/ Institut Pasteur"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmii.2012.11.005","article-title":"Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6","volume":"47","author":"YH Deng","year":"2014","journal-title":"Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.micinf.2010.11.002","article-title":"The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis","volume":"13","author":"BY Jeon","year":"2011","journal-title":"Microbes Infect"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0463.2011.02815.x","article-title":"Recombinant BCG coexpressing Ag85B, CFP10, and interleukin-12 induces multifunctional Th1 and memory T cells in mice","volume":"120","author":"CW Lin","year":"2012","journal-title":"APMIS"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"e87340","DOI":"10.1371\/journal.pone.0087340","article-title":"The candidate TB vaccine, MVA85A, induces highly durable Th1 responses","volume":"9","author":"M Tameris","year":"2014","journal-title":"PLoS One"},{"issue":"25","key":"ref31","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"MA Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1574-695X.2007.00322.x","article-title":"Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL\/6 mice","volume":"51","author":"Y Xu","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molimm.2014.06.007","article-title":"A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice","volume":"62","author":"W Li","year":"2014","journal-title":"Mol Immunol"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"J Dietrich","year":"2005","journal-title":"J Immunol"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"e0141687","DOI":"10.1371\/journal.pone.0141687","article-title":"A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults","volume":"10","author":"S Sheehan","year":"2015","journal-title":"PloS one"},{"issue":"33","key":"ref36","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"R Sun","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"MA Horwitz","year":"2003","journal-title":"Infection and immunity"},{"issue":"6326","key":"ref38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"CK Stover","year":"1991","journal-title":"Nature"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/CVI.00075-15","article-title":"Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors","volume":"22","author":"BE Hart","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-gamma from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection","volume":"190","author":"AM Green","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"e33406","DOI":"10.1371\/journal.pone.0033406","article-title":"Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination","volume":"7","author":"AG Fraga","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/CVI.00368-09","article-title":"Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis","volume":"17","author":"MI Henao-Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/529049","article-title":"T Cells and Tuberculosis: Beyond Interferon-gamma","volume":"197","author":"A Lalvani","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"e0004450","DOI":"10.1371\/journal.pntd.0004450","article-title":"Interferon-gamma Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice","volume":"10","author":"R Bieri","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1128\/IAI.73.9.6101-6109.2005","article-title":"Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice","volume":"73","author":"E Roy","year":"2005","journal-title":"Infection and immunity"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"JM Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri3813","article-title":"Advancing host-directed therapy for tuberculosis","volume":"15","author":"RS Wallis","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"e2101","DOI":"10.1371\/journal.pntd.0002101","article-title":"Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease","volume":"7","author":"FS Sarfo","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"5403","key":"ref49","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence","volume":"283","author":"KM George","year":"1999","journal-title":"Science"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1039\/b803101k","article-title":"Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria","volume":"25","author":"H Hong","year":"2008","journal-title":"Natural product reports"},{"issue":"2016","key":"ref51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.trivac.2016.04.001","article-title":"Immunogenicity and protection conferred by a recombinant Mycobacterium marinum vaccine against Buruli ulcer","volume":"5","author":"BE Hart","year":"2016","journal-title":"Trials in Vaccinology"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/mt.2009.60","article-title":"Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis","volume":"17","author":"J Mu","year":"2009","journal-title":"Mol Ther"},{"issue":"14","key":"ref53","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2004.10.007","article-title":"Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection","volume":"23","author":"U Palendira","year":"2005","journal-title":"Vaccine"},{"key":"ref54","first-page":"76","article-title":"Homologous and heterologous immunity in infections of mice with Mycobacterium ulcerans and Mycobacterium balnei","volume":"76","author":"F Fenner","year":"1957","journal-title":"Am Rev Tuberc"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005229","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T00:00:00Z","timestamp":1482364800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:17:17Z","timestamp":1540325837000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005229"}},"subtitle":[],"editor":[{"given":"Gerd","family":"Pluschke","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,12]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005229","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005229","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,12]]}}}